E-cigarette Usage in UK Reaches Record High Levels

Aug.12.2024
E-cigarette Usage in UK Reaches Record High Levels
The e-cigarette use among UK adults has reached a record high, with 11% using them, totaling 5.6 million people.

According to a report from the Shropshire Star on August 12th, the use of e-cigarettes among adults in the UK has reached a record high. The latest data shows that 11% of UK adults use e-cigarettes, equating to 5.6 million people.


According to data from Action on Smoking and Health (ASH) in the UK, approximately 53% of e-cigarette users, which is equivalent to 3 million people, were previously traditional cigarette smokers. Currently, the proportion of people who use both traditional cigarettes and e-cigarettes has increased from 17% in 2021 to 32% in 2024, equivalent to 2.2 million people.


Ash's deputy chief executive Hazel Cheeseman said:


Smoking remains the biggest preventable killer in the UK, and e-cigarettes are one of the important tools to help smokers quit in order to achieve a smoke-free nation for both current and future generations.


Professor Sanjay Agrawal, Special Advisor on Tobacco Issues at the Royal College of Physicians and Consultant in Respiratory and Intensive Care Medicine at the University Hospitals of Leicester NHS Trust, added:


In the past few years, almost all of the patients I have encountered who have successfully quit smoking have done so by using e-cigarettes, without which they may have not been able to quit. E-cigarettes have been used by quit smoking services and the NHS to support smokers, but we can still more widely use this tool to help millions of people who are still smoking to quit.


According to reports, in July of this year, the Labour government restarted its plan to introduce the Tobacco and E-Cigarette Bill, which could gradually raise the age limit for purchasing tobacco and prevent anyone born after January 1, 2009 from legally purchasing tobacco. The bill could also impose restrictions on the flavors, packaging, and display of e-cigarettes.


Ms. Chisman emphasized that the proposed e-cigarette legislation should focus on preventing children from using e-cigarettes, rather than adults who are looking to quit smoking. She added:


In recent years, millions of people have successfully quit smoking by using e-cigarettes, extending their healthy lifespan and boosting national productivity. There is an urgent need for stricter regulations on e-cigarettes, but it is important that these regulations target teenage e-cigarette use specifically, without hindering their use as a smoking cessation aid.


Henry Gregg, Director of External Affairs for the British Lung Foundation, said:


Quitting smoking can be very difficult, and it is great to see that many smokers are finding e-cigarettes to be a very effective tool for quitting. However, in order to help more smokers quit, the government must increase investment in local smoking cessation services. In recent years, these services have faced significant cuts, but they have excelled in supporting people to quit smoking permanently and address the deadly consequences of smoking.


According to a survey, half of smokers believe that e-cigarettes are as harmful as traditional cigarettes, and 60% of non-e-cigarette users who smoke also share the same view.


A spokesperson for the UK Department of Health and Social Care stated:


Although e-cigarettes can be an effective tool for quitting smoking, health advice clearly states that non-smoking children and adults should never use e-cigarettes. The upcoming Tobacco and E-Cigarette Act will protect future generations from the harm of tobacco and nicotine, saving thousands of lives. By establishing a healthier society, it will also contribute to building a healthier economy.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
British American Tobacco (BAT) plans to cut about 5,500 jobs globally and shift around 3,500 roles to strategic partners by the end of 2026, affecting about 9,000 roles in total, as the company seeks to simplify operations, strengthen technology capabilities and deliver £600 million in annual savings by 2028.
BAT
Jun.29
Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
A South Korean lawmaker has asked China’s tobacco regulator to clarify rules for e-cigarettes containing synthetic nicotine amid questions over product declarations and possible tax losses. The dispute exposes gaps between Chinese export requirements and destination-market rules, while underscoring the global impact of China’s licensing and traceability policies.
Jul.10
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18